L. Pazzi

V. Conti1
A. Vaccheri1
C. Biagi1
M. Melis1
M. Donati1
1V. Conti
1A. Vaccheri
1C. Biagi
1M. Melis
1M. Donati
Learn More
The purpose of this study is to conduct a comparative analysis of the suspected adverse drug reactions (ADRs) associated with intravitreal bevacizumab, ranibizumab and pegaptanib in the WHO database in order to have a real-life information on these drugs, which now is only based on data coming from clinical trials. ADR reports for intravitreal use of(More)
  • 1